[{"id":"3f4c5428-51b9-428c-8b7e-591df451a815","acronym":"","url":"https://clinicaltrials.gov/study/NCT05768529","created_at":"2023-03-14T14:01:52.026Z","updated_at":"2024-07-02T16:35:36.640Z","phase":"Phase 1/2","brief_title":"Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma","source_id_and_acronym":"NCT05768529","lead_sponsor":"Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd","biomarkers":" IL6","pipe":" | ","alterations":" CD20 positive • CD20 negative","tags":["IL6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD20 positive • CD20 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • U16"],"overall_status":"Recruiting","enrollment":" Enrollment 100","initiation":"Initiation: 03/28/2023","start_date":" 03/28/2023","primary_txt":" Primary completion: 12/31/2024","primary_completion_date":" 12/31/2024","study_txt":" Completion: 12/31/2026","study_completion_date":" 12/31/2026","last_update_posted":"2023-09-21"}]